Universal-Beteiligungs- und Servicegesellschaft’s Oruka Therapeutics ORKA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Buy	+2,789	New	+$186K	﹤0.01%	1960

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ORKA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 2,789 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #1960 among its holdings.

255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 2,789 shares of Oruka Therapeutics worth $265K as of Q2 2026.
Oruka Therapeutics was a new Universal-Beteiligungs- und Servicegesellschaft position in Q2 2026.
Oruka Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1960 holding.
255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.